DOCSLIB.ORG

Infectious and Parasitic Diseases

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Infectious and Parasitic Diseases NOMS ICD10/9 CROSSWALK FOR CAUSE OF DEATH TITLES IN PMR ANALYSIS Final (Full Listing) 3/24/2008 by C. Robinson & C. Gersic Note to User when analyzing National Occupational Mortality Surveillance data for PMRs or MORs: The codes below each cause of death title below that begin with an alphabetic letter are the 10th revision codes. The codes following, that are numeric, are the corresponding 9th revision codes. INFECTIOUS AND PARASITIC DISEASES A00 –B99 001 -139 TUBERCULOSIS A15 –A19 010 -018, 137 PULMONARY TUBERCULOSIS A16, B909, J65, O980 010 -012 TUBERCULOUS FIBROSIS OF LUNG (SILICOTUBERCULOSIS) A15 –A16 0114 BACTERIAL DISEASES A20 –A49 020 -041 SEPTICAEMIA A40 –A41 038 HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION (AIDS) B20 –B24 042 -044 VIRAL HEPATITIS A B15 0700, 0701 VIRAL HEPATITIS B B16 0702, 0703 NON-A, NON-B VIRAL HEPATITIS B17 –B19 0704 – 0706, 0709 SARCOIDOSIS D86 135 MALIGNANT NEOPLASMS (MN) C00 –C97 140 -208 MN LIP, ORAL CAVITY AND PHARYNX C00 –C14, C462 140 -149 MN LIP C00 140 MN TONGUE C01 –C02 141 MN OTHER PARTS BUCCAL CAVITY C03 –C08, C462 142 -145 MN SALIVARY GLANDS C07 –C08 142 MN PHARYNX C09 –C14 146 -149 MN DIGESTIVE ORGANS AND PERITONEUM C15 –C26, C48, 150 - 159 MN ESOPHAGUS C15 150 MN STOMACH C16 151 MN SMALL INTESTINE, INCLUDING DUODENUM C17 152 MN COLON 2 C18 153 MN RECTUM, RECTOSIGMOID JUNCTION AND ANUS C19 –C21 154 MN BILIARY PASSAGES, LIVER, AND GALL BLADDER C22 –C24 155 -156 MN GALLBLADDER AND EXTRAHEPATIC BILE DUCTS C23 –C24, 156 MN PANCREAS C25 157 MN PERITONEUM & OTHER DIGESTIVE ORGANS C26, C48 158 -159 MN RESPIRATORY SYSTEM C30 –C39 160 -165 MN NASAL CAVITIES, MIDDLE EAR AND ACCESSORY SINUSES C30 –C31 160 MN LARYNX C32 161 MN TRACHEA, BRONCHUS AND LUNG C33 –C34 162 MN PERITONEUM AND PLEURA C384, C48 158, 163 MN PLEURA (80% MESOTHELIOMA IN MALES) C384 163 MN BONE, CONNECTIVE TISSUE, SKIN, AND BREAST C40 -C44, C49 -C50 170 - 175 MN BONE AND ARTICULAR CARTILAGE C40 –C41 170 MN MESOTHELIOMA (no codes before 1999) C45 MN KAPOSI SARCOMA (no codes before 1999) C46 MN CONNECTIVE AND OTHER SOFT TISSUE C49, C461 171 MALIGNANT MELANOMA OF SKIN C43 172 OTHER MALIGNANT NEOPLASM OF SKIN C44, C460,C469 173 MN BREAST C50 174 175 MN FEMALE GENITAL ORGANS C51 –C58 179 - 184 MN CERVIX UTERI C53 180 MN OTHER PARTS OF UTERUS C54 -C55, C58 179, 181 -182 MN OVARY AND OTHER UTERINE ADNEXA C56, C570–C574,C578 183 MN OTHER AND UNSPECIFIED FEMALE GENITAL ORGANS C51 –C52, C577, C579 184 MN MALE GENITAL ORGANS C60 –C63 185 -187 MN PROSTATE C61 185 MN TESTIS C62 186 MN PENIS AND OTHER MALE GENITAL ORGANS 3 C60, C63 187 MN SCROTUM C632, C639 1877, 1879 BLADDER CANCER (includes in situ) C67 188, 2337, 2367, 2394 MN URINARY ORGANS C64 -C68 188, 1893 -1899 MN KIDNEY C64 –C66 1890-1892 MN BLADDER C67 188 MN OTHER AND UNSPECIFIED URINARY ORGANS C68 1893 -1899 MN OF OTHER AND UNSPECIFIED SITES C69 –C80 190 -199 MN EYE C69 190 MN BRAIN C71 191 BRAIN AND NERVOUS SYSTEM, ALL NEOPLASMS EXCEPT SECONDARY C70 –C72, D33, D42 –D43 191 -192, 225, 2375 -2379, 2396 - 2397 MN BRAIN AND NERVOUS SYSTEM C-47 ,C70 -C72 191 -192 MN THYROID GLAND AND OTHER ENDOCRINE GLANDS C73 193 MN SECONDARY, ILL-DEFINED AND UNSPECIFIED SITES C74 –C80, C467 –C468, C60, C64, C97 187, 194 -199 MN LYMPHATIC AND HEMATOPOIETIC TISSUE C81 C463, C82 –C85, C880, C883, C914, C96, C887, C889, C90, C910– C913, C915 – C919, C92 –C95 200 -208, 2733 HODGKIN'S DISEASE C81 201 NON-HODGKIN'S LYMPHOMAS C463, C82 –C85, C880, C883, C914, C96 200, 202, 2733 MULTIPLE MYELOMA C887, C889, C90 203 LEUKEMIA AND ALEUKEMIA C910–C913, C915–C919, C92 –C95 204 -208 LYMPHATIC LEUKEMIA C91 204 ACUTE MYELOID LEUKEMIA C920 2050 CHRONIC MYELOID LEUKEMIA C921 2051 BENIGN NEOPLASMS OF EYE, BRAIN AND CNS D31 –D33 224 -225 NEOPLASMS OF UNSPECIFIED NATURE OF EYE, BRAIN, AND NERVOUS SYSTEM D42 – D43 , Q850 2375 – 2379 , 2396 - 2397 Other Benign & Unspecified Nature Neoplasms D00 – D30 , D34 – D41 , D44 – D45 , D47 – D48 210 – 223 , 226 – 236 , 2370 – 2374 , 238 , 2390 – 2395 , 2398 – 2399 , 2731 DISEASES OF BLOOD AND BLOOD-FORMING ORGANS D510,D460–D464,D50 ,D511-D519,D52 -D64, –D65 –D69 ,D70 –D75 ,D77 ,D467– D469,D892,I88 ,R72 281 ,2810 -2819 ,282 -289 POLYCYTHEMIA VERA D45 2384 4 PERNICIOUS ANEMIAS D510 2810 APLASTIC ANEMIA D60 -D61 284 NON-AUTOIMMUNE AND UNSPECIFIED HEMOLYTIC ANEMIAS D592, D593, D594, D599 2831,2839 OTHER AND UNSPECIFIED APLASTIC ANEMIA D618, D619 2848,2849 AGRANULOCYTOSIS D70 2880 METHEMOGLOBINEMIA D74 2897 ANEMIAS OF OTHER & UNSPECIFIED TYPE D460-D464, D50, D511-D519, D52 -D64 280, 2811 -2819, 282 -285 COAGULATION DEFECTS, PURPURA & OTHER HEMORRHAGIC CONDITIONS D65 -D69 286 -287 ALL OTHER DISEASE OF BLOOD FORMING ORGANS D467-D469, D70 -D75, D77, D892, I88, R72 288 -289 DIABETES MELLITUS E10 –E14 250 MENTAL DISORDERS F00 –F99 290 -319 MENTAL DISORDERS, EXCLUDING SCHIZOPHRENIA AND RETARDATION F00 –F19, F30 –F69, F80 –F99 290 -294, 296 ALCOHOLISM F10, G312 291, 303, 3050 MENTAL DISORDERS RELATED TO SUBSTANCE ABUSE F10 –F19 291 -292, 303 -305 MENTAL DISORDERS RELATED TO ALCOHOL ABUSE F10 291, 303, 3050 MENTAL DISORDERS RELATED TO DRUG ABUSE F11 –F19 292, 304 DRUG-RELATED DEATHS F11 –F19 292, 304, 3052-3059, 850 -858, 9500-9505, 9620, 9800-9805 MENTAL DISORDERS ASSOCIATED WITH SOLVENT EXPOSURE F18 292, 3059, 3046, 2940 PSYCHOTIC DISORDERS F20 –F39 290 -299 NON-PSYCHOTIC DISORDERS F40 –F69, F80 –F99 300 -302 304 3051-3059 306-319 7836 7846 NEUROTIC AND PERSONALITY DISORDERS F40 –F48, F60 –F69 300 -301 306 308 - 309 DISEASES OF THE NERVOUS SYSTEM AND SENSE ORGANS G00 –G99, H00 –H95 320 -389 PARKINSON'S DISEASE (GROUPED) G20 –G22 332 ANTERIOR HORN CELL DISEASE INC MOTOR NEURONE DISEASE (AMLS) G12 335 PARKINSON’S DISEASE G20 –G22 332 ALZHEIMER'S AND OTHER DEGENERATIVE DISEASE G30 -G32 290, 3310,3311 MULTIPLE SCLEROSIS AND OTHER DEMYLENATING DISEASE G35 –G37 340 -341 EPILEPSY G40 -G41 345 DISORDERS OF THE PERIPHERAL NERVOUS SYSTEM 5 G50 –G73 350 -359 OTHER DISEASES OF THE NERVOUS SYSTEM & SENSE ORGANS G08 ,G10-G11 G13–G19 G23-G29 G38–G39 G42-G47 ,G453,G473,G478 ,G74 ,H00-H01 H020-H025,H027-H029,H04 -H95 ,R441 325 ,330 -337 ,341 -344 346-357 360-389 TOXIC ENCEPHALOPATHY G92 3483 MONONEURITIS OF UPPER LIMB AND MONONEURITIS MULTIPLEX G560, G562, G563 3540,3542,3543 MYONEURAL DISORDERS G70 –G73 358 DISEASES OF THE HEART I00 –I52, I970-I971,I978-I979 390 -398 401- 405, 410-414, 420 -429 RHEUMATIC HEART DISEASE & FEVER I00 –I09 390 -398 HYPERTENSION WITH HEART DISEASE I11, I13, 402, 404 HYPERTENSION WITHOUT HEART DISEASE I10, I12 401, 403, 405 ISCHEMIC HEART DISEASE I20 –I22, I24 –I25, I513, I516 410 -414, 4292 ACUTE MYOCARDIAL INFARCTION (AMI) I21 410 OTHER FORMS OF HEART DISEASE I30 –I52 411 -414 DISEASES OF THE PULMONARY CIRCULATION I26 –I28 415 -417 OTHER HEART DISEASE (PERICARDITIS, ENDOCARDITIS, MYOCARDITIS, ETC.) I30 –I33 ,I40 ,I50 ,I510–I512,I514–I515,I517–I521,I970-I971,I978–I979 420 -423 ,428 ,4290-4291,4293-4299 CHRONIC DISEASE OF ENDOCARDIUM I34 –I38 424 CARDIOMYOPATHY I42, I528 425 DILATED CARDIOMYOPATHY I420 4254 -4259 CARDIOMEGALY I42, 528 4293 CONDUCTIVE DISORDERS, DYSRHYTHMIAS I44 –I49, R001, R008 426 427 CHRONIC PULMONARY HEART DISEASE I279 416 CEREBROVASCULAR DISEASE (STROKE) G450 -G452, G454 –G459, I60 –I69 430 -438 DISEASES OF ARTERIES, ARTERIOLES, AND CAPILLARIES I70 –I79 440 -448 RAYNAUD'S SYNDROME I730 4430 DISEASES OF VEINS AND LYMPHATICS I80 –I89 451 -457 DISEASES OF THE RESPIRATORY SYSTEM J00 – J99 460 -520 ACUTE RESPIRATORY INFECTIONS EXCEPT INFLUENZA & PNEUMONIA J00 –J01, J028–J029 J038-J039, J04 –J06, J20 –J22 460 -466 INFLUENZA J10 –J11 487 PNEUMONIA 6 A481, J12 –J18 480 -486 CHRONIC OBSTRUCTIVE PULMONARY DISEASE J40 –J44 490 -492,496 ASTHMA J45 –J46 493 BRONCHIECTASIS J47 494 HYPERSENSITIVITY PNEUMONITIS (FARMERS LUNG, BAGASSOSIS, BIRD LUNG, SUBEROSIS, MALTWORKERS, MUSHROOM, MAPLEBARK, VENTILATORY FUNGI, OTHER) J67 495 PNEUMOCONIOSES (OCCUPATIONAL LUNG DISEASES) (COAL, ASBESTOS, SILICA, DUST, COTTON, OTHER) J60 –J66, J68-J70, 500 -508 COALWORKERS' PNEUMOCONIOSIS J60 500 ASBESTOSIS J61 501 SILICOSIS J62 502 OTHER AND UNSPECIFIED PNEUMOCONIOSES (ALUMINIUM, BERYLLIUM, BYSSINOSIS,ETC.) J63 -J64 503 -505 PNEUMOCONIOSIS DUE TO OTHER INORGANIC DUST (ALUMINUM, BERYLLIUM, BAIXITE, ETC.) J63 503 PNEUMOPATHY DUE TO INHALATION OF SPECIFIC ORGANIC DUST (BYSSINOSIS, CANNABINOSIS, FLAX) J66 504 LUNG CONDITIONS DUE TO SOLIDS, FUMES, VAPORS, RADIATION—EXCLUD FOOD INHALATION J68, J691, J698, J70 506 ,5071, 5078 508 RESPIRATORY CONDITIONS DUE TO CHEMICAL FUMES, VAPORS, OILS, ESSENCES & SOLIDS J68, J691 506, 5071 RESPIRATORY CONDITIONS DUE TO CHEMICAL FUMES AND VAPORS J68 506 OTHER RESPIRATORY DISEASE J30 –J33, J341 –J348, J35 –J39 ,J69 –J96 ,J98 –J99 ,R091 470 -478 ,494 -495 ,510 -519 DISEASES OF THE DIGESTIVE SYSTEM K00 –K93, R682 520 -579 DISEASES OF ESOPHAGUS K20 –K23 530 DISEASES OF STOMACH AND DUODENUM K25 –K31, K599 531 -537 PEPTIC ULCER K27 531 -534 HERNIA OF ABDOMINAL CAVITY AND INTESTINAL OBSTRUCTION K40 –K46, K56 550 -553, 560 DISEASES OF LIVER K70 –K77 570 -573 CIRRHOSIS & OTHER CHRONIC LIVER DISEASE K70, K73 –K74, K760 571 ACUTE LIVER FAILURE K72 570 TOXIC HEPATITIS K71 5733 DISORDERS OF GALLBLADDER AND BILIARY TRACT K80 –K83 574 -576 DISEASES OF PANCREAS 7 K85 –K86 577 OTHER DISEASES OF DIGESTIVE SYSTEM K00 –K22 ,K35 –K38 ,K50 –K55 ,K57 –K58 ,K590–K598,K60 -K66 ,K71 –K72 ,K75,K761– K769,K78 –K92 ,R682,402 ,520 -530 ,540 -543 ,555 -558 ,562 -570 ,572 -579 ,9974 DISEASES OF THE SKIN AND SUBCUTANEOUS TISSUE L00 –L99 680 -709 INFECTIONS OF THE SKIN & SUBCUTANEOUS TISSUE J340, L00 –L08 ,L303,L88 680 -685 ,6860,6868,6869 OTHER DISEASES OF THE SKIN & SUBCUTANEOUS TISSUES
Load more

Recommended publications
  • Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy
    395 Hypersensitivity Pneumonitis: Challenges in Diagnosis and Management, Avoiding Surgical Lung Biopsy Ferran Morell, MD1,2 Ana Villar, MD2,3 Iñigo Ojanguren, MD2,3 Xavier Muñoz, MD2,3 María-Jesús Cruz, PhD2,3 1 Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Catalonia, Spain Address for correspondence Ferran Morell, MD, Vall d’Hebron Institut 2 Ciber de Enfermedades Respiratorias (CIBERES), Barcelona, Spain de Recerca (VHIR), PasseigValld’Hebron, 119-129, 08035 Barcelona, 3 Servei de Pneumologia, Hospital Universitari Vall d’Hebron, Catalonia, Spain (e-mail: [email protected]). Barcelona, Spain Semin Respir Crit Care Med 2016;37:395–405. Abstract This review presents an update of the currently available information related to Keywords hypersensitivity pneumonitis, with a particular focus on the contribution of several ► hypersensitivity techniques in the diagnosis of this condition. The methods discussed include proper pneumonitis elaboration of a complete medical history, targeted auscultation, detection of specific ► bronchoalveolar immunoglobulin G antibodies against the most common antigens causing this disease, lavage skin tests, antigen-specific lymphocyte activation assays, bronchoalveolar lavage, and ► fi speci c inhalation cryobiopsy. Special emphasis is placed on the relevant contribution of specificinhalation challenge challenge (bronchial challenge test). Surgical lung biopsy is presented as the ultimate ► bronchial challenge recourse, to be used when the diagnosis cannot be reached through the other methods test covered.
    [Show full text]
  • Nebulizers: Diagnosis Codes – Medicare Advantage Policy Appendix
    UnitedHealthcare® Medicare Advantage Policy Appendix: Applicable Code List Nebulizers: Diagnosis Codes This list of codes applies to the Medicare Advantage Policy Guideline titled Approval Date: September 8, 2021 Nebulizers. Applicable Codes The following list(s) of procedure and/or diagnosis codes is provided for reference purposes only and may not be all inclusive. The listing of a code does not imply that the service described by the code is a covered or non-covered health service. Benefit coverage for health services is determined by the member specific benefit plan document and applicable laws that may require coverage for a specific service. The inclusion of a code does not imply any right to reimbursement or guarantee claim payment. Other Policies and Guidelines may apply. Diagnosis Code Description For HCPCS Codes A7003, A7004, and E0570 A15.0 Tuberculosis of lung A22.1 Pulmonary anthrax A37.01 Whooping cough due to Bordetella pertussis with pneumonia A37.11 Whooping cough due to Bordetella parapertussis with pneumonia A37.81 Whooping cough due to other Bordetella species with pneumonia A37.91 Whooping cough, unspecified species with pneumonia A48.1 Legionnaires' disease B20 Human immunodeficiency virus [HIV] disease B25.0 Cytomegaloviral pneumonitis B44.0 Invasive pulmonary aspergillosis B59 Pneumocystosis B77.81 Ascariasis pneumonia E84.0 Cystic fibrosis with pulmonary manifestations J09.X1 Influenza due to identified novel influenza A virus with pneumonia J09.X2 Influenza due to identified novel influenza A virus with other
    [Show full text]
  • Diapositivo 1
    A.C. Nunes1, A. Domingues1, M. Almeida-Silva1,2, S. Viegas2, C. Viegas2 1 Escola Superior de Tecnologia e Saúde de Lisboa, Instituto Politécnico de Lisboa 2 Instituto Tecnológico e Nuclear, Instituto Superior Técnico, Universidade Técnica de Lisboa. Cork is a light, porous, impermeable material extracted from the bark of some trees. The most widely used cork is obtained from the cork tree Health Effects (Quercus suber). It is estimated that the area occupied by cork oaks in the Iberian Peninsula is around 33% in Portugal and 23% in Spain [1]. The studied articles refer two major diseases associated with this Portugal is the largest cork producing country in the world, followed by occupational setting, occupational asthma and Suberosis. Spain, and its industry is an important economical resource [2].The Occupational asthma is a disease whose origin is related to the processes used in the manufacture of cork depend on the end product to be obtained, being the production of stoppers for wine bottles the exposure to a particular factor in a workplace. Recent studies have main application. Most of the cork is stored under dark humid and identified Chrysonilia sitophila as a cause for this occupational disease moldy conditions. During the manufacturing process, workers are in the cork and logging industry [4, 5]. This fungi is a common mould exposed to an environment that is heavily contaminated with cork dust found in cork samples analyzed [6]. [3]. Due to this repeated exposure to moldy cork dust, cork workers are at risk for developing occupational lung diseases such as occupational Suberosis is the term applied to hypersensitivity pneumonitis due to asthma and Suberosis.
    [Show full text]
  • Diagnostic Yield of Specific Inhalation Challenge in Hypersensitivity Pneumonitis
    ERJ Express. Published on August 19, 2014 as doi: 10.1183/09031936.00060714 ORIGINAL ARTICLE IN PRESS | CORRECTED PROOF Diagnostic yield of specific inhalation challenge in hypersensitivity pneumonitis Xavier Mun˜oz1,2,3,Mo´nica Sa´nchez-Ortiz1,2, Ferran Torres4, Ana Villar1,2, Ferran Morell1,2 and Marı´a-Jesu´s Cruz1,2 Affiliations: 1Pulmonology Service, Medicine Dept, Hospital Universitari Vall d’Hebron, Universitat Auto`noma de Barcelona, Barcelona, Spain. 2CIBER Enfermedades Respiratorias (Ciberes), Spain. 3Dept of Cell Biology, Physiology and Immunology, Universitat Auto`noma de Barcelona, Barcelona, Spain. 4Biostatistics and Data Management Platform, IDIBAPS, Hospital Clinic, Biostatistics Unit, School of Medicine, Universitat Auto`noma de Barcelona, Barcelona, Spain. Correspondence: Xavier Mun˜oz, Servei de Pneumologia, Hospital Universitari Vall d’Hebron, Passeig Vall d’Hebron, 119, 08035 Barcelona, Spain. E-mail: [email protected] ABSTRACT Reliable methods are needed to diagnose hypersensitivity pneumonitis. Theaimofthestudywasto establish the diagnostic yield of specific inhalation challenge (SIC) in patients with hypersensitivity pneumonitis. All patients with suspected hypersensitivity pneumonitis in whom SIC was performed (n5113) were included. SIC was considered positive when patients showed a decrease of .15% in forced vital capacity (FVC) or .20% in diffusing capacity of the lung for carbon dioxide, or a decrease of 10% to 15% in FVC accompanied by a temperature increase of 0.5uC within 24 h of inhalation of the antigen. SIC was positive to the agents tested in 68 patients: 64 received a diagnosis of hypersensitivity pneumonitis and SIC results were considered false-positive in the remaining four patients. In the SIC- negative group (n545), 24 patients received a diagnosis of hypersensitivity pneumonitis and SIC results were considered false-negative, and 21 patients were diagnosed with other respiratory diseases.
    [Show full text]
  • Occupational Lung Diseases
    Occupational Lung diseases Dr Deepak Aggarwal Dept. Of Pulmonary Medicine To be discussed…. • Pneumoconiosis • Hypersensitivity Pneumonitis PNEUMOCONIOSIS Pneumoconioses are pulmonary diseases caused by mineral dust inhalation in workplace The specific types of pneumoconioses are named by the substance inhaled (e.g., silicosis, asbestosis, anthracosis) PNEUMOCONIOSIS Mineral Dust‐Induced Lung Disease Coal dust Simple coal workers' pneumoconiosis: Coal mining macules and nodules Complicated coal workers' pneumoconiosis: PMF Silica Silicosis Sandblasting, quarrying, mining, stone cutting, foundry work, ceramics Asbestos Asbestosis pleural effusions, pleural plaques, or Mining, milling, diffuse fibrosis; mesothelioma; carcinoma of the and fabrication of ores and lung and larynx materials; installation and removal of insulation Fibrogenic pneumoconioses "true pneumoconioses" • asbestosis • berylliosis • • silicosis talcosis • kaolin pneumoconiosis. • hard metal disease • coal workers' • aluminum fibrosis, pneumoconiosis Shaver's disease Non‐fibrogenic pneumoconioses benign pneumoconioses Causes: • antimony • iron • barium • tin • boric acid • titanium • manganese • bismuth PNEUMOCONIOSIS Pathogenesis The development of a pneumoconiosis depends on (1) the amount of dust retained in the lung and airways (2) the size, shape, and buoyancy of the particles (3) solubility and physiochemical reactivity (4) the possible additional effects of other irritants (e.g., concomitant tobacco smoking) PNEUMOCONIOSIS Pathogenesis (1)The amount of dust retained
    [Show full text]
  • 336 Naegeli's
    336 INDEX N Naegeli's Narrowing - continued - disease 287.1 - artery NEC - continued - leukemia, monocytic (M9863/3) 205.1 -- cerebellar 433.8 Naffziger's syndrome 353.0 -- choroidal 433.8 Naga sore (see also Ulcer, skin) 707.9 -- communicative posterior 433.8 Nagele's pelvis 738.6 -- coronary 414.0 - with disproportion 653.0 --- congenital 090.5 -- causing obstructed labor 660.1 --- due to syphilis 093.8 -- fetus or newborn 763.1 -- hypophyseal 433.8 Nail - see also condition -- pontine 433.8 - biting 307.9 -- precerebral NEC 433.9 - patella syndrome 756.8 --- multiple or bilateral 433.3 Nanism, nanosomia (see also Dwarfism) -- vertebral 433.2 259.4 --- with other precerebral artery 433.3 - pituitary 253.3 --- bilateral 433.3 - renis, renalis 588.0 auditory canal (external) 380.5 Nanukayami 100.8 cerebral arteries 437.0 Napkin rash 691.0 cicatricial - see Cicatrix Narcissism 302.8 eustachian tube 381.6 Narcolepsy 347 eyelid 374.4 Narcosis - intervertebral disc or space NEC - see - carbon dioxide (respiratory) 786.0 Degeneration, intervertebral disc - due to drug - joint space, hip 719.8 -- correct substance properly - larynx 478.7 administered 780.0 mesenteric artery (with gangrene) 557.0 -- overdose or wrong substance given or - palate 524.8 taken 977.9 - palpebral fissure 374.4 --- specified drug - see Table of drugs - retinal artery 362.1 and chemicals - ureter 593.3 Narcotism (chronic) (see also Dependence) - urethra (see also Stricture, urethra) 598.9 304.9 Narrowness, abnormal. eyelid 743.6 - acute NEC Nasal- see condition correct
    [Show full text]
  • Diagnostic Code Descriptions (ICD9) Respiratory System
    DISEASES OF THE RESPIRATORY SYSTEM ACUTE RESPIRATORY INFECTIONS (460 – 466.1) 460 ACUTE NASOPHARYNGITIS (COMMON COLD) 461 ACUTE SINUSITIS 461.0 MAXILLARY 461.1 FRONTAL 461.2 ETHMOIDAL 461.3 SPHENOIDAL 461.8 OTHER 461.9 UNSPECIFIED 462 ACUTE PHARYNGITIS 463 ACUTE TONSILLITIS 464 ACUTE LARYNGITIS AND TRACHEITIS 464.0 ACUTE LARYNGITIS 464.1 ACUTE TRACHEITIS 464.2 ACUTE LARYNGOTRACHEITIS 464.3 ACUTE EPIGLOTTITIS 464.4 CROUP 465 ACUTE UPPER RESPIRATORY INFECTIONS OF MULTIPLE OR UNSPECIFIED SITE 465.0 ACUTE LARYNGOPHARYNGITIS 465.8 OTHER MULTIPLE SITES 465.9 UNSPECIFIED SITE 466 ACUTE BRONCHITIS AND BRONCHIOLITIS 466.0 ACUTE BRONCHITIS 466.1 ACUTE BRONCHIOLITIS OTHER DISEASES OF UPPER RESPIRATORY TRACT (470 – 478.9) 470 DEFLECTED NASAL SEPTUM 471 NASAL POLYPS 471.0 POLYP OF NASAL CAVITY 471.1 POLYPOID SINUS DEGENERATION 471.8 OTHER POLYP OF SINUS 471.9 UNSPECIFIED 472 CHRONIC PHARYNGITIS AND NASOPHARYNGITIS 472.0 CHRONIC RHINITIS 472.1 CHRONIC PHARYNGITIS 472.2 CHRONIC NASOPHARYNGITIS 473 CHRONIC SINUSITIS 473.0 MAXILLARY 473.1 FRONTAL 473.2 ETHMOIDAL 473.3 SPHENOIDAL 473.8 OTHER 473.9 UNSPECIFIED 474 CHRONIC DISEASE OF TONSILS AND ADENOIDS 474.0 CHRONIC TONSILLITIS 474.1 HYPERTROPHY OF TONSILS AND ADENOIDS 474.2 ADENOID VEGETATIONS 474.8 OTHER CHRONIC DISEASE OF TONSILS AND ADENOIDS 474.9 UNSPECIFIED 475 PERITONSILLAR ABSCESS 476 CHRONIC LARYNGITIS AND LARYNGOTRACHEITIS 476.0 CHRONIC LARYNGITIS 476.1 CHRONIC LARYNGOTRACHEITIS 477 ALLERGIC RHINITIS 477.0 DUE TO POLLEN 477.8 DUE TO OTHER ALLERGEN 477.9 CAUSE UNSPECIFIED 478 OTHER DISEASES OF
    [Show full text]
  • Respiratory Disease in Cork Workers ('Suberosis')1
    Thorax: first published as 10.1136/thx.28.4.409 on 1 July 1973. Downloaded from Thorax (1973), 28, 409. Respiratory disease in cork workers ('suberosis')1 J. CORTEZ PIMENTEL and RAMIRO AVILA Department of Pathology of Sanatorio D. Carlos I and Department of Chest Diseases and Institute of Pathology, Faculty of Medicine, University of Lisbon, Portugal Pimentel, J. Cortez, and Avila, Ramiro (1973). Thorax, 28, 409-423. Respiratory disease in cork workers ('suberosis'). A clinical, immunological, and histological study of 63 workers in the cork industry with bronchopulmonary manifestations is described. From this study, it was possible to recognize three types of reaction to the inhalation of cork dust: asthma-like syndromes, extrinsic allergic alveolitis, and chronic bronchitis with bronchiec- tasis. The place ofhistological (lung biopsy and scalene node biopsy) and immunological met- hods in the diagnosis of these different forms of the disease is evaluated. The high incidence of precipitins to Penicilliumfrequentans is stressed because the antigens produced by this fungus seem to be more pathogenic than those produced by the mouldy cork itself. The histological studies have demonstrated extrapulmonary foci of disease and have also revealed for the first time, abnormalities in the lungs of symptomless subjects. Pathological changes present in the lungs of patients with the chronic form of extrinsic allergic alveolitis, long after removal from exposure to cork dust, are also described. The experimental material of Horta and Cancella (1956) is reviewed in the light ofpresentknowledge, andthe similarity between the lesions produced in animals and those found in cork workers is noted. Finally, especial im- portance is attached to the finding of cork dust within the lesions, the technique for its identifi- cation and staining being described.
    [Show full text]
  • Occupational Medicine Symposia
    OCCUPATIONAL MEDICINE SYMPOSIA U.S. DEPARTMENT OF HEALTH, EDUCATION, AND WELFARE Public Health Service Center for Disease Control National Institute for Occupational Safety and Health Division of Occupational Health Programs ----- - . Rockville,. ·-- --r---�--Maryland May 1975 This publication contains major papers presented at the 34th American Medical Association Congress on Occupational Health, held September 9 to 10, 1974 in Chicago, Illinois. The Congress was supported in part by the National Institute for Occupational Safety and Health through Contract No. CDC-99-74-30. Dr. Henry Howe was AMA Project Director and compiled the initial proceedings from the verbatim transcript. The assistance of the following individuals is gratefully acknowledged: Ernest B. Howard, M.D. William R. Barclay, M.D. Asher J. Finkel, M.D. Henry F. Howe, M.D. CDC-NIOSH David J. Sencer, M.D. Marcus M. Key, M.D. Raymond T. ~oore, M.D. A. Walter Hoover, M.D. Leo A. Sanders Marilyn K. Hutchison, M.D. HEW Publication No. (NIOSH) 75-189 FOREWORD A primary goal of the National Institute for Occupational Safety and Health is to promote effective health care for American working men and women. Since the passage of the Occupational Safety and Health Act of 1970, a growing number of family practitioners and internists have entered the part-time practice of occupational medicine. Helping these physicians to incorporate the concepts and skills of occupational medical practice into the total delivery of health services is a major consideration of the Institute's Division of Occupational Health Programs. Toward this end, NIOSH co-sponsored the AMA's 34th Annual Congress on Occupational Health and cooperated in developing the scientific program for the Congress.
    [Show full text]
  • ICD-9 Diagnosis Codes Effective 10/1/2007 (V25.0) Source: Centers for Medicare and Medicaid Services
    ICD-9 Diagnosis Codes effective 10/1/2007 (v25.0) Source: Centers for Medicare and Medicaid Services 0010 CHOLERA D/T VIB CHOLERAE 0082 AEROBACTER ENTERITIS 01104 TB LUNG INFILTR-CULT DX 0011 CHOLERA D/T VIB EL TOR 0083 PROTEUS ENTERITIS 01105 TB LUNG INFILTR-HISTO DX 0019 CHOLERA NOS 00841 STAPHYLOCOCC ENTERITIS 01106 TB LUNG INFILTR-OTH TEST 0020 TYPHOID FEVER 00842 PSEUDOMONAS ENTERITIS 01110 TB LUNG NODULAR-UNSPEC 0021 PARATYPHOID FEVER A 00843 INT INFEC CAMPYLOBACTER 01111 TB LUNG NODULAR-NO EXAM 0022 PARATYPHOID FEVER B 00844 INT INF YRSNIA ENTRCLTCA 01112 TB LUNG NODUL-EXAM UNKN 0023 PARATYPHOID FEVER C 00845 INT INF CLSTRDIUM DFCILE 01113 TB LUNG NODULAR-MICRO DX 0029 PARATYPHOID FEVER NOS 00846 INTES INFEC OTH ANEROBES 01114 TB LUNG NODULAR-CULT DX 0030 SALMONELLA ENTERITIS 00847 INT INF OTH GRM NEG BCTR 01115 TB LUNG NODULAR-HISTO DX 0031 SALMONELLA SEPTICEMIA 00849 BACTERIAL ENTERITIS NEC 01116 TB LUNG NODULAR-OTH TEST 00320 LOCAL SALMONELLA INF NOS 0085 BACTERIAL ENTERITIS NOS 01120 TB LUNG W CAVITY-UNSPEC 00321 SALMONELLA MENINGITIS 00861 INTES INFEC ROTAVIRUS 01121 TB LUNG W CAVITY-NO EXAM 00322 SALMONELLA PNEUMONIA 00862 INTES INFEC ADENOVIRUS 01122 TB LUNG CAVITY-EXAM UNKN 00323 SALMONELLA ARTHRITIS 00863 INT INF NORWALK VIRUS 01123 TB LUNG W CAVIT-MICRO DX 00324 SALMONELLA OSTEOMYELITIS 00864 INT INF OTH SML RND VRUS 01124 TB LUNG W CAVITY-CULT DX 00329 LOCAL SALMONELLA INF NEC 00865 INTES INFEC CALCIVIRUS 01125 TB LUNG W CAVIT-HISTO DX 0038 SALMONELLA INFECTION NEC 00866 INTES INFEC ASTROVIRUS 01126 TB LUNG W CAVIT-OTH
    [Show full text]
  • (001-139) Includes: Diseases Generally Recogniz
    ICD9 Cause of Death list 1 of 609 CLASSIFICATION OF DISEASES AND INJURIES I. INFECTIOUS AND PARASITIC DISEASES (001-139) Includes: diseases generally recognized as communicable or transmissible as well as a few diseases of unknown but possibly infectious origin Excludes: acute respiratory infections (460-466) influenza (487.-) certain localized infections Note: Categories for "late effects" of infectious and parasitic diseases are to be found at 137.- to 139.- INTESTINAL INFECTIOUS DISEASES (001-009) Excludes: helminthiases (120-129) 001 Cholera 001.0 Due to Vibrio cholerae 001.1 Due to Vibrio cholerae el tor 001.9 Unspecified 002 Typhoid and paratyphoid fevers 002.0 Typhoid fever Typhoid (fever) (infection) [any site] 002.1 Paratyphoid fever A 002.2 Paratyphoid fever B 002.3 Paratyphoid fever C 002.9 Paratyphoid fever, unspecified 003 Other salmonella infections Includes: infection or food poisoning by Salmonella [any serotype] ICD9 Cause of Death list 2 of 609 003.0 Salmonella gastroenteritis Salmonellosis 003.1 Salmonella septicaemia 003.2 Localized salmonella infections Salmonella: Salmonella: arthritis osteomyelitis meningitis pneumonia 003.8 Other 003.9 Unspecified Salmonella infection NOS 004 Shigellosis Includes: bacillary dysentery 004.0 Shigella dysenteriae Infection by group A Shigella (Schmitz) (Shiga) 004.1 Shigella flexneri Infection by group B Shigella 004.2 Shigella boydii Infection by group C Shigella 004.3 Shigella sonnei Infection by group D Shigella 004.8 Other 004.9 Unspecified 005 Other food poisoning (bacterial) Excludes: salmonella infections (003.-) toxic effect of noxious foodstuffs (988.-) ICD9 Cause of Death list 3 of 609 005.0 Staphylococcal food poisoning Staphylococcal toxaemia specified as due to food 005.1 Botulism Food poisoning due to Clostridium botulinum 005.2 Food poisoning due to Clostridium perfringens [Cl.
    [Show full text]
  • Wildfires in Northern California: Emergency Department Visits, 2017
    Wildfires in Northern California: Emergency Department Visits in 2017 We wish to acknowledge the HCUP Partner organization from the California Office of Statewide Health Planning and Development (OSHPD) that contributed to the HCUP State Databases used in this study. May 29, 2019 Recommended Citation: Wildfires in Northern California: Emergency Department Visits in 2017. Healthcare Cost and Utilization Project. ONLINE. August 19, 2019. Agency for Healthcare Research and Quality. Available: www.hcup-us.ahrq.gov/reports.jsp. Table of Contents Overview ....................................................................................................................................................... 1 Air Quality Index ........................................................................................................................................... 1 Methods ........................................................................................................................................................ 2 Groupings of California Counties .............................................................................................................. 2 Air Quality Data ......................................................................................................................................... 4 HCUP Databases ........................................................................................................................................ 4 Conditions of Interest ..............................................................................................................................
    [Show full text]